Financhill
Back

Mineralys Therapeutics, Inc. Vs. Global Payments, Inc. Industry Stock Comparison

Sell
38

MLYS
Mineralys Therapeutics, Inc.

Last Price:
$27.01
Seasonality Move:
1.47%
Sell
22

GPN
Global Payments, Inc.

Last Price:
$64.05
Seasonality Move:
2.51%
Sell
38
Mineralys Therapeutics, Inc. (MLYS) is a Sell

Is Mineralys Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Mineralys Therapeutics, Inc. [MLYS] share price is $26.97. The Score for MLYS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MLYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Global Payments, Inc. (GPN) is a Sell

Is Global Payments, Inc. a Buy, Sell or Hold?

  • The current Global Payments, Inc. [GPN] share price is $64.05. The Score for GPN is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • GPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MLYS Stock Price Chart

What is Mineralys Therapeutics, Inc.'s stock price today?

  • The Mineralys Therapeutics, Inc. share price today is $26.97
    The current trend is relatively stagnant and MLYS is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPN Stock Price Chart

What is Global Payments, Inc.'s stock price today?

  • The Global Payments, Inc. share price today is $64.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPN is experiencing slight selling pressure.

MLYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 53.19 Buy
Chaikin Money Flow: 1516947 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24 - 28.04) Buy
Bollinger Bands (100): (27.03 - 39.19) Sell

GPN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.35 Sell
Relative Strength Index (14 RSI): 33.87 Sell
Chaikin Money Flow: -920501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.1 - 75.54) Sell
Bollinger Bands (100): (70.58 - 79.52) Sell

MLYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.85 Buy
20-day SMA: 25.39 Buy
50-day SMA: 28.13 Sell
200-day SMA: 29.59 Sell
8-day EMA: 25.48 Buy
20-day EMA: 25.73 Buy
50-day EMA: 28.05 Sell
200-day EMA: 28.5 Sell

GPN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.58 Sell
20-day SMA: 69.75 Sell
50-day SMA: 72.69 Sell
200-day SMA: 79.34 Sell
8-day EMA: 66.92 Sell
20-day EMA: 69.46 Sell
50-day EMA: 72.38 Sell
200-day EMA: 79.48 Sell

Mineralys Therapeutics, Inc. Earnings Growth & MLYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.27 per share.

Global Payments, Inc. Earnings Growth & GPN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.60 per share, a decrease next quarter of $0.23 per share, an increase this year of $1.58 per share, and an increase next year of $2.43 per share.

Mineralys Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Global Payments, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):